2011
DOI: 10.4103/0970-4388.79933
|View full text |Cite
|
Sign up to set email alerts
|

Cellulitis on face in a patient with congenital afibrinogenemia

Abstract: Congenital afibrinogenemia is a rare coagulation disorder, with an estimated prevalence of 1 : 1,000,000, characterized by a complete absence to reduced level of circulating fibrinogen. This article presents a case of congenital afibrinogenemia, which presented as cellulitis on the face.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 1 publication
0
2
0
Order By: Relevance
“…The treatment of accessible bleeding points in afibrinogenemia patients is with the local application of pressure, vasoconstrictor drugs and, if necessary, sutures. Drugs that are commonly used include vitamin K, protamine sulfate and calcium gluconate, and anti‐fibrinolytic agents, for example, ɛ amino‐caproic acid and the kallikrein inhibitor, trasylol, heparin, desamino‐8‐d‐arginine vasopressin, androgens and topical hemostats such as thrombin 8–10 …”
Section: Discussionmentioning
confidence: 99%
“…The treatment of accessible bleeding points in afibrinogenemia patients is with the local application of pressure, vasoconstrictor drugs and, if necessary, sutures. Drugs that are commonly used include vitamin K, protamine sulfate and calcium gluconate, and anti‐fibrinolytic agents, for example, ɛ amino‐caproic acid and the kallikrein inhibitor, trasylol, heparin, desamino‐8‐d‐arginine vasopressin, androgens and topical hemostats such as thrombin 8–10 …”
Section: Discussionmentioning
confidence: 99%
“…CFD is a bleeding disorder with a prevalence rate of ∼8% among the rare bleeding disorders with an estimated prevalence of 1 in a million [1][2][3]. Prevalence data from India are sparse with only a few case reports [6][7][8][9][10][11][12][13][14][15][16]. Sumitha et al [17] described the molecular basis of CFD in 27 patients, and Shetty et al [18] reported fibrinogen deficiencies in 12.1% of the 321 rare clotting factor deficiency cohort.…”
Section: Congenital Fibrinogen Deficiencymentioning
confidence: 99%